Patients with Omenn syndrome present with early onset generalized erythodermia, lymphadenopathy, hepatosplenomegaly, protracted diarrhea, failure to thrive, eosinophilia, increased
Ig E levels, defective B and T lymphocyte function, greatly increased numbers of T
lymphocytes, and death usually before 5 - 6 months of age. Additional findings include lymphocytosis and histiocytosis within skin and other tissues. Protein loss due to diarrhea and exudative erythrodermia often leads to generalized edema. The presence of a massive inflamatory infiltrate confers to the skin a unique appearance and consistency (pachydermia). Alopecia is a frequent finding. Infections and severe malnutrition are the main causes of death. Septicemia often arising from skin infections is common.
Diagnosis
Diagnostic recommendations
Additional Information
Diagnostic laboratories
Clinical:
Genetic:
Therapeutic options
- Bone marrow transplantation is the only treatment of SCID. Other recommendations include intravenous gamma-globulin infusion, irradiation of all blood products, antibiotherapy.
- BMT, supportive treatment, prophylaxis of infection and tailored conditioning regimen, National Marrow Donor Program
- Omenn syndrome, eMedicine
Research programs, clinical trials
- Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders, ClinicalTrial.gov
- Yale University
- Recombination and expression of antigen receptor genes
- Howard Hughes Medical Institute